Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore the quickest ways to raise your credit score with high-impact actions you can implement immediately.
8,939 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
A top China logistics platform generated $1.8 billion in revenue last year, yet one investor cashed out a $6 million ...
A single, massive swap stirred chaos in the DeFi space when extreme slippage warnings were ignored. The trader receiv...
Berkshire Hathaway owns a big slice of Apple, and that slice throws off dividend income. This deep dive breaks down w...
Venture capital giants surge into crypto and AI with a historic fund, stirring a volatile mix of policy headlines and...
Palantir Technologies has delivered a staggering 625% rally since 2020, but a mix of government ties and governance s...
PayPal is widening access to PYUSD, allowing users in 70 countries to hold and move its stablecoin. The shift could c...
Bitcoin faces a pivotal test as Moody’s recession odds rise toward a historic point. Macro signals suggest crypto cou...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...